• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

更正：人α-防御素5是一种用于区分炎症性肠病的候选生物标志物。

Correction: Human alpha defensin 5 is a candidate biomarker to delineate inflammatory bowel disease.

作者信息

Williams Amanda D, Korolkova Olga Y, Sakwe Amos M, Geiger Timothy M, James Samuel D, Muldoon Roberta L, Herline Alan J, Goodwin J Shawn, Izban Michael G, Washington Mary K, Smoot Duane T, Ballard Billy R, Gazouli Maria, M'Koma Amosy E

出版信息

PLoS One. 2017 Dec 6;12(12):e0189551. doi: 10.1371/journal.pone.0189551. eCollection 2017.

DOI:10.1371/journal.pone.0189551
PMID:29211779
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5718520/
Abstract

[This corrects the article DOI: 10.1371/journal.pone.0179710.].

摘要

[本文更正了文章的数字对象标识符：10.1371/journal.pone.0179710。]

相似文献

1
Correction: Human alpha defensin 5 is a candidate biomarker to delineate inflammatory bowel disease.更正：人α-防御素5是一种用于区分炎症性肠病的候选生物标志物。
PLoS One. 2017 Dec 6;12(12):e0189551. doi: 10.1371/journal.pone.0189551. eCollection 2017.
2
Correction: Linking bacterial enterotoxins and alpha defensin 5 expansion in the Crohn's colitis: A new insight into the etiopathogenetic and differentiation triggers driving colonic inflammatory bowel disease.更正：克罗恩病结肠炎中细菌肠毒素与α-防御素5扩增的关联：对驱动结肠炎性肠病的病因发病机制及分化触发因素的新见解。
PLoS One. 2024 May 29;19(5):e0304732. doi: 10.1371/journal.pone.0304732. eCollection 2024.
3
Human alpha defensin 5 is a candidate biomarker to delineate inflammatory bowel disease.人α-防御素5是一种用于鉴别炎症性肠病的候选生物标志物。
PLoS One. 2017 Aug 17;12(8):e0179710. doi: 10.1371/journal.pone.0179710. eCollection 2017.
4
Correction: Inflammatory Bowel Disease: How Effective Is TNF-α Suppression?更正：炎症性肠病：肿瘤坏死因子-α抑制疗法的效果如何？
PLoS One. 2017 Feb 2;12(2):e0170865. doi: 10.1371/journal.pone.0170865. eCollection 2017.
5
Correction: Genomic and Clinical Effects Associated with a Relaxation Response Mind-Body Intervention in Patients with Irritable Bowel Syndrome and Inflammatory Bowel Disease.更正：与放松反应身心干预对肠易激综合征和炎症性肠病患者的基因组及临床影响相关的研究
PLoS One. 2017 Feb 21;12(2):e0172872. doi: 10.1371/journal.pone.0172872. eCollection 2017.
6
Correction: Corticosteroid Use and Complications in a US Inflammatory Bowel Disease Cohort.更正：美国炎症性肠病队列中皮质类固醇的使用与并发症
PLoS One. 2018 May 9;13(5):e0197341. doi: 10.1371/journal.pone.0197341. eCollection 2018.
7
Correction: Serum anti-glycan-antibodies in relatives of patients with inflammatory bowel disease.更正：炎症性肠病患者亲属的血清抗聚糖抗体。
PLoS One. 2018 Sep 4;13(9):e0203709. doi: 10.1371/journal.pone.0203709. eCollection 2018.
8
Correction: Allele-specific DNA methylation of disease susceptibility genes in Japanese patients with inflammatory bowel disease.更正：日本炎症性肠病患者疾病易感性基因的等位基因特异性DNA甲基化
PLoS One. 2019 Feb 5;14(2):e0212148. doi: 10.1371/journal.pone.0212148. eCollection 2019.
9
Correction: Trends in emergency department visits and hospitalization rates for inflammatory bowel disease in the era of biologics.更正：生物制剂时代炎症性肠病的急诊科就诊趋势和住院率
PLoS One. 2019 May 7;14(5):e0216768. doi: 10.1371/journal.pone.0216768. eCollection 2019.
10
Correction: Novel Synthetic Oxazines Target NF-κB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo.更正：新型合成恶嗪在体外针对结肠癌中的核因子κB以及在体内针对炎症性肠病
PLoS One. 2017 Apr 6;12(4):e0175659. doi: 10.1371/journal.pone.0175659. eCollection 2017.

本文引用的文献

1
Human alpha defensin 5 is a candidate biomarker to delineate inflammatory bowel disease.人α-防御素5是一种用于鉴别炎症性肠病的候选生物标志物。
PLoS One. 2017 Aug 17;12(8):e0179710. doi: 10.1371/journal.pone.0179710. eCollection 2017.